In addition, inhibiting the effects of other therapies on PD-1 expression can also yield considerable results, for instance, exogenous short 5′-triphosphate-modified RNA (ppp-RNA) can direct the immune response toward tumor cells. This evidence concerns the gene PDCD1 and neoplasm.